Crossref
journal-article
Elsevier BV
Neurobiology of Disease (78)
References
121
Referenced
337
10.1093/hmg/8.4.567
/ Hum. Mol. Genet. / A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease by Abbas (1999)10.1016/S0896-6273(00)80886-7
/ Neuron / Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system by Abeliovich (2000)10.1016/S0304-3940(99)00311-0
/ Neurosci. Lett. / Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores by Bayer (1999)10.1111/j.1749-6632.1994.tb21791.x
/ Ann. N.Y. Acad. Sci. / Peroxynitrite versus hydroxyl radical: The role of nitric oxide in superoxide-dependent cerebral injury by Beckman (1994)10.2307/3576299
/ Radiat. Res. / Poly(ADP-ribose) in the cellular response to DNA damage by Berger (1985)10.1212/WNL.42.10.1894
/ Neurology / Parkinson's disease in twins studied with 18F-dopa and positron emission tomography by Burn (1992)10.1212/WNL.50.2.513
/ Neurology / Failure to find the alpha-synuclein gene missense mutation (G209A) in 100 patients with younger onset Parkinson's disease by Chan (1998)10.1016/S0166-2236(97)01213-7
/ Trends Neurosci. / The synucleins: A family of proteins involved in synaptic function, plasticity, neurodegeneration and disease by Clayton (1998)10.1038/3311
/ Nat. Med. / Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease by Conway (1998)10.1021/bi991447r
/ Biochemistry / Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid by Conway (2000)10.1073/pnas.97.2.571
/ Proc. Natl. Acad. Sci. USA / Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy by Conway (2000){'key': '10.1006/nbdi.2000.0319_RF12', 'first-page': '264', 'article-title': 'Poly(ADP-ribose) polymerase inhibitors protect against MPTP-induced depletions of striatal dopamine and cortical noradrenaline in C57B1/6 mice', 'volume': '729', 'author': 'Cosi', 'year': '1996', 'journal-title': 'Brain Res.'}
/ Brain Res. / Poly(ADP-ribose) polymerase inhibitors protect against MPTP-induced depletions of striatal dopamine and cortical noradrenaline in C57B1/6 mice by Cosi (1996){'key': '10.1006/nbdi.2000.0319_RF13', 'first-page': '57', 'article-title': 'The role of peroxynitrite in nitric oxide-mediated toxicity', 'volume': '196', 'author': 'Crow', 'year': '1995', 'journal-title': 'Curr. Top. Microbiol. Immunol.'}
/ Curr. Top. Microbiol. Immunol. / The role of peroxynitrite in nitric oxide-mediated toxicity by Crow (1995)10.1016/S0092-8674(00)80629-7
/ Cell / New animal models for Parkinson's disease by Dawson (2000)10.1016/0968-0004(94)90280-1
/ Trends Biochem. Sci. / Poly(ADP-ribose) polymerase: A molecular nick-sensor by de Murcia (1994)10.1046/j.1471-4159.2000.0742213.x
/ J. Neurochem. / Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo [In Process Citation] by Dehmer (2000)10.1016/S0140-6736(86)92471-2
/ Lancet / Lipid peroxidation as cause of nigral cell death in Parkinson's disease [Letter] by Dexter (1986)10.1111/j.1471-4159.1990.tb08814.x
/ J. Neurochem. / Decreased ferritin levels in brain in Parkinson's disease by Dexter (1990)10.1111/j.1471-4159.1989.tb09133.x
/ J. Neurochem. / Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease by Dexter (1989)10.1002/ana.410320716
/ Ann. Neurol. / Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research Group by Dexter (1992)10.1038/399a032
/ Nature / Prospects for new restorative and neuroprotective treatments in Parkinson's disease by Dunnett (1999)10.1097/00001756-199812010-00029
/ Neuroreport / Mutation screening in exons 3 and 4 of alpha-synuclein in sporadic Parkinson's and sporadic and familial dementia with Lewy bodies cases by El-Agnaf (1998)10.1016/S0014-5793(98)01419-7
/ FEBS Lett. / Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of alpha-synuclein protein implicated in Parkinson's disease by El-Agnaf (1998)10.1038/8820
/ Nat. Genet. / Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions by Engelender (1999)10.1093/hmg/8.1.81
/ Hum. Mol. Genet. / A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor by Farrer (1999)10.1038/35006074
/ Nature / A Drosophila model of Parkinson's disease [see Comments] by Feany (2000)10.1002/1531-8249(200005)47:5<632::AID-ANA11>3.0.CO;2-N
/ Ann. Neurol. / Alpha-synuclein and Parkinson's disease: Selective neurodegenerative effect of alpha-synuclein fragment on dopaminergic neurons in vitro and in vivo [In Process Citation] by Forloni (2000)10.1016/S0079-6123(08)61770-7
/ Prog. Brain Res. / Astrocytes and Parkinson's disease by Forno (1992){'key': '10.1006/nbdi.2000.0319_RF29', 'first-page': '600', 'article-title': "Similarities and differences between MPTP-induced parkinsonsim and Parkinson's disease. Neuropathologic considerations", 'volume': '60', 'author': 'Forno', 'year': '1993', 'journal-title': 'Adv. Neurol.'}
/ Adv. Neurol. / Similarities and differences between MPTP-induced parkinsonsim and Parkinson's disease. Neuropathologic considerations by Forno (1993){'key': '10.1006/nbdi.2000.0319_RF30', 'first-page': '809', 'article-title': 'Filaments of Lewy bodies contain insoluble cytoskeletal elements', 'volume': '140', 'author': 'Galloway', 'year': '1992', 'journal-title': 'Am. J. Pathol.'}
/ Am. J. Pathol. / Filaments of Lewy bodies contain insoluble cytoskeletal elements by Galloway (1992){'key': '10.1006/nbdi.2000.0319_RF31', 'first-page': '313', 'article-title': 'Pathobiology of the Lewy body', 'volume': '80', 'author': 'Galvin', 'year': '1999', 'journal-title': 'Adv. Neurol.'}
/ Adv. Neurol. / Pathobiology of the Lewy body by Galvin (1999)10.1073/pnas.96.23.13450
/ Proc. Natl. Acad. Sci. USA / Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein by Galvin (1999)10.1038/ng0398-262
/ Nat. Genet. / A susceptibility locus for Parkinson's disease maps to chromosome 2p13 by Gasser (1998)10.1074/jbc.274.12.7619
/ J. Biol. Chem. / Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro by Giasson (1999)10.1007/s004010051135
/ Acta Neuropathol. (Berlin) / alpha-Synuclein immunoreactivity in dementia with Lewy bodies: Morphological staging and comparison with ubiquitin immunostaining [In Process Citation] by Gomez-Tortosa (2000)10.1097/00005072-199804000-00006
/ J. Neuropathol. Exp. Neurol. / Protein nitration in Parkinson's disease by Good (1998)10.1038/70918
/ Nat. Med. / NOS knockouts and neuroprotection [news; comment] by Grunewald (1999)10.1212/WNL.54.2.504
/ Neurology / A kindred with Parkinson's disease not showing genetic linkage to established loci by Gwinn-Hardy (2000)10.1038/nm0996-1017
/ Nat. Med. / Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons [see Comments] by Hantraye (1996)10.1016/S0304-3940(99)00465-6
/ Neurosci. Lett. / The Ile93Met mutation in the ubiquitin carboxy-terminal-hydrolase-L1 gene is not observed in European cases with familial Parkinson's disease by Harhangi (1999)10.1016/0006-291X(90)90498-C
/ Biochem. Biophys. Res. Commun. / 1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles by Hasegawa (1990)10.1097/00001756-199903170-00011
/ Neuroreport / Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro by Hashimoto (1999)10.1111/j.1750-3639.1999.tb00552.x
/ Brain Pathol. / Alpha-synuclein in Lewy body disease and Alzheimer's disease by Hashimoto (1999)10.1002/ana.410440612
/ Ann. Neurol. / Molecular genetic analysis of a novel Parkin gene in Japanese families with autosomal recessive juvenile parkinsonism: Evidence for variable homozygous deletions in the Parkin gene in affected individuals by Hattori (1998)10.1006/bbrc.1998.9134
/ Biochem. Biophys. Res. Commun. / Point mutations (Thr240Arg and Gln311Stop) [correction of Thr240Arg and Ala311Stop] in the Parkin gene by Hattori (1998)10.1038/311467a0
/ Nature / Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors by Heikkila (1984)10.1002/ana.410360209
/ Ann. Neurol. / Discordant twins with Parkinson's disease: Positron emission tomography and early signs of impaired cognitive circuits by Holthoff (1994)10.1097/00005072-199804000-00005
/ J. Neuropathol. Exp. Neurol. / Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity by Irizarry (1998)10.1212/WNL.47.1.160
/ Neurology / Clinical analysis of 17 patients in 12 Japanese families with autosomal-recessive type juvenile parkinsonism by Ishikawa (1996)10.1002/(SICI)1098-2396(19991215)34:4<305::AID-SYN6>3.0.CO;2-#
/ Synapse / Methamphetamine- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity in inducible nitric oxide synthase-deficient mice by Itzhak (1999)10.1073/pnas.82.7.2173
/ Proc. Natl. Acad. Sci. USA / Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: Uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity by Javitch (1985){'key': '10.1006/nbdi.2000.0319_RF52', 'first-page': '267', 'article-title': "Iron and ferritin in substantia nigra in Parkinson's disease", 'volume': '60', 'author': 'Jellinger', 'year': '1993', 'journal-title': 'Adv. Neurol.'}
/ Adv. Neurol. / Iron and ferritin in substantia nigra in Parkinson's disease by Jellinger (1993)10.1021/bi972776r
/ Biochemistry / Regulation of phospholipase D2: Selective inhibition of mammalian phospholipase D isoenzymes by alpha- and beta-synucleins by Jenco (1998){'key': '10.1006/nbdi.2000.0319_RF54', 'first-page': '57', 'article-title': "Oxidative stress in Parkinson's disease and other neurodegenerative disorders", 'volume': '44', 'author': 'Jenner', 'year': '1996', 'journal-title': 'Pathol. Biol. (Paris)'}
/ Pathol. Biol. (Paris) / Oxidative stress in Parkinson's disease and other neurodegenerative disorders by Jenner (1996)10.1002/ana.410440712
/ Ann. Neurol. / Understanding cell death in Parkinson's disease by Jenner (1998)10.1074/jbc.274.36.25481
/ J. Biol. Chem. / alpha-synuclein binds to Tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356 by Jensen (1999)10.1074/jbc.M000099200
/ J. Biol. Chem. / Microtubule-associated protein 1B is a component of cortical Lewy bodies and binds alpha-synuclein filaments by Jensen (2000)10.1074/jbc.273.41.26292
/ J. Biol. Chem. / Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation by Jensen (1998)10.1006/nlme.1997.3795
/ Neurobiol. Learn. Mem. / Synelfin regulation during the critical period for song learning in normal and isolated juvenile zebra finches by Jin (1997)10.1126/science.286.5438.309
/ Science / The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase [see comments] by Joazeiro (1999)10.1038/33416
/ Nature / Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism [see Comments] by Kitada (1998)10.1097/00001756-199902250-00035
/ Neuroreport / Transgenic mice expressing a dominant negative mutant interleukin-1beta converting enzyme show resistance to MPTP neurotoxicity by Klevenyi (1999)10.1523/JNEUROSCI.20-01-00001.2000
/ J. Neurosci. / Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by Klivenyi (2000)10.1006/nbdi.1998.0191
/ Neurobiol. Dis. / Manganese superoxide dismutase overexpression attenuates MPTP toxicity by Klivenyi (1998)10.1146/annurev.ne.11.030188.000501
/ Annu. Rev. Neurosci. / MPTP toxicity: implications for research in Parkinson's disease by Kopin (1988)10.1097/00001756-200001170-00041
/ Neuroreport / MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons by Kowall (2000)10.1038/ng0298-106
/ Nat. Genet. / Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease [Letter] by Kruger (1998)10.1056/NEJM199810083391506
/ N. Engl. J. Med. / Parkinson's disease. First of two parts by Lang (1998)10.1056/NEJM199810153391607
/ N. Engl. J. Med. / Parkinson's disease. Second of two parts by Lang (1998)10.1212/WNL.47.6_Suppl_3.153S
/ Neurology / The etiology of Parkinson's disease with emphasis on the MPTP story by Langston (1996)10.1002/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F
/ Ann. Neurol. / Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure by Langston (1999)10.1007/BF01076101
/ Mol. Cell. Biochem. / Molecular and biochemical features of poly (ADP-ribose) metabolism by Lautier (1993)10.1007/s004390050845
/ Hum. Genet. / Deletions in the Parkin gene and genetic heterogeneity in a Greek family with early onset Parkinson's disease by Leroy (1998)10.1038/70978
/ Nat. Med. / Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease [see Comments] by Liberatore (1999)10.1073/pnas.96.20.11364
/ Proc. Natl. Acad. Sci. USA / RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination by Lorick (1999)10.1002/path.1711610210
/ J. Pathol. / Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases by Lowe (1990)10.1016/S0140-6736(05)60746-5
/ Lancet by Lucking (1998)10.1056/NEJM200005253422103
/ N. Engl. J. Med. / Association between early-onset Parkinson's disease and mutations in the parkin gene by Lucking (2000)10.1073/pnas.96.10.5774
/ Proc. Natl. Acad. Sci. USA / Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism by Mandir (1999)10.1212/WNL.53.8.1858
/ Neurology / Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease by Maraganore (1999)10.1212/WNL.46.1.231
/ Neurology / [123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease by Marek (1996)10.1126/science.287.5456.1265
/ Science / Dopaminergic loss and inclusion body formation in alpha-synuclein mice: Implications for neurodegenerative disorders by Masliah (2000)10.1006/exnr.1996.6406
/ Exp. Neurol. / S-Methylthiocitrulline, a neuronal nitric oxide synthase inhibitor, protects against malonate and MPTP neurotoxicity by Matthews (1997)10.1016/S0753-3322(99)80075-4
/ Biomed. Pharmacother. / Genetics of Parkinson's disease by Mizuno (1999)10.1016/0925-4439(95)00038-6
/ Biochim. Biophys. Acta / Role of mitochondria in the etiology and pathogenesis of Parkinson's disease by Mizuno (1995)10.1016/S0968-0004(99)01381-X
/ Trends Biochem. Sci. / A novel transactivation domain in parkin [Letter] by Morett (1999)10.1212/WNL.51.3.890
/ Neurology / Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q [see Comments] by Mori (1998)10.1523/JNEUROSCI.19-14-05782.1999
/ J. Neurosci. / alpha-Synuclein shares physical and functional homology with 14-3-3 proteins by Ostrerova (1999)10.1212/WNL.52.3.651
/ Neurology / Mutated alpha-synuclein gene in two Greek kindreds with familial PD: Incomplete penetrance? by Papadimitriou (1999)- Parkinson, J. 1817, An essay on the shaking palsy. Sherwood, Neely, and Jones.
10.1212/WNL.51.6.1757
/ Neurology / Mutation, sequence analysis, and association studies of alpha-synuclein in Parkinson's disease by Parsian (1998)10.1002/ana.410410213
/ Ann. Neurol. / Dopaminergic function in familial Parkinson's disease: A clinical and 18F-dopa positron emission tomography study by Piccini (1997)10.1097/00005072-199305000-00001
/ J. Neuropathol. Exp. Neurol. / Pathology and biology of the Lewy body by Pollanen (1993)10.1126/science.274.5290.1197
/ Science / Mapping of a gene for Parkinson's disease to chromosome 4q21-q23 [see Comments] by Polymeropoulos (1996)10.1126/science.276.5321.2045
/ Science / Mutation in the alpha-synuclein gene identified in families with Parkinson's disease [see Comments] by Polymeropoulos (1997)10.1073/pnas.93.10.4565
/ Proc. Natl. Acad. Sci. USA / Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity by Przedborski (1996)10.1523/JNEUROSCI.12-05-01658.1992
/ J. Neurosci. / Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity by Przedborski (1992)10.1016/S0165-6147(00)01470-X
/ Trends Pharmacol. Sci. / Reply: A new look at the pathogenesis of Parkinson's disease by Przedborski (2000)10.1038/12647
/ Nat. Genet. / Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice [see Comments] by Saigoh (1999)10.1002/ana.410320503
/ Ann. Neurol. / The identification of presymptomatic parkinsonism: Clinical and [18F]dopa positron emission tomography studies in an Irish kindred by Sawle (1992)10.1002/ana.410440714
/ Ann. Neurol. / Mitochondria in the etiology and pathogenesis of Parkinson's disease by Schapira (1998)10.1097/00005072-198807000-00006
/ J. Neuropathol. Exp. Neurol. / Astrocytic responses to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in cat and mouse brain by Schneider (1988)10.1046/j.1471-4159.1995.64020936.x
/ J. Neurochem. / Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice by Schulz (1995){'key': '10.1006/nbdi.2000.0319_RF104', 'first-page': '1500', 'article-title': "Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients", 'volume': '39', 'author': 'Seibyl', 'year': '1998', 'journal-title': 'J. Nucl. Med.'}
/ J. Nucl. Med. / Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients by Seibyl (1998)10.1002/1531-8249(199905)45:5<668::AID-ANA19>3.0.CO;2-Z
/ Ann. Neurol. / Immunohistochemical and subcellular localization of Parkin protein: Absence of protein in autosomal recessive juvenile parkinsonism patients by Shimura (1999)10.1002/ana.410360305
/ Ann. Neurol. / Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia [see Comments] by Sian (1994)10.1016/S0140-6736(87)90722-7
/ Lancet / Free radicals, lipid peroxidation, and Parkinson's disease [Letter] by Smith (1987)10.1111/j.1750-3639.1998.tb00162.x
/ Brain Pathol. / Frontotemporal dementia and Parkinsonism linked to chromosome 17: A new group of tauopathies by Spillantini (1998)10.1073/pnas.95.11.6469
/ Proc. Natl. Acad. Sci. USA / alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies by Spillantini (1998)10.1038/42166
/ Nature / Alpha-synuclein in Lewy bodies [Letter] by Spillantini (1997)10.1016/S0165-6147(98)01193-6
/ Trends Pharmacol. Sci. / Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion by Szabo (1998){'key': '10.1006/nbdi.2000.0319_RF112', 'first-page': '367', 'article-title': 'Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders', 'volume': '152', 'author': 'Takeda', 'year': '1998', 'journal-title': 'Am. J. Pathol.'}
/ Am. J. Pathol. / Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders by Takeda (1998){'key': '10.1006/nbdi.2000.0319_RF113', 'first-page': '73', 'article-title': 'Processing of MPTP by monoamine oxidases: Implications for molecular toxicology', 'volume': '23', 'author': 'Trevor', 'year': '1987', 'journal-title': 'J. Neural. Transm. Suppl.'}
/ J. Neural. Transm. Suppl. / Processing of MPTP by monoamine oxidases: Implications for molecular toxicology by Trevor (1987)10.1038/sj.cdd.4400432
/ Cell Death Differ. / Fatal attractions: Abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia [see Comments] by Trojanowski (1998)10.1073/pnas.90.23.11282
/ Proc. Natl. Acad. Sci. USA / Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease by Ueda (1993)10.1093/hmg/7.4.751
/ Hum. Mol. Genet. / Sequencing of the alpha-synuclein gene in a large series of cases of familial Parkinson's disease fails to reveal any further mutations. The European Consortium on Genetic Susceptibility in Parkinson's Disease (GSPD) by Vaughan (1998)10.1002/1531-8249(200004)47:4<521::AID-ANA18>3.0.CO;2-B
/ Ann. Neurol. / Synphilin-1 is present in Lewy bodies in Parkinson's disease by Wakabayashi (2000)10.1007/s004010050918
/ Acta Neuropathol. (Berlin) / Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy by Wakabayashi (1998)10.1001/archneur.55.12.1521
/ Arch. Neurol. / The G209A mutation in the alpha-synuclein gene is not detected in familial cases of Parkinson disease in non-Greek and/or Italian populations by Wang (1998)10.1126/science.2530630
/ Science / The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase by Wilkinson (1989)10.1002/ana.410410218
/ Ann. Neurol. / Maternal inheritance in Parkinson's disease by Wooten (1997)
Dates
Type | When |
---|---|
Created | 22 years, 11 months ago (Sept. 18, 2002, 11:46 a.m.) |
Deposited | 5 years, 8 months ago (Dec. 16, 2019, 11:44 a.m.) |
Indexed | 2 weeks, 3 days ago (Aug. 19, 2025, 6:10 a.m.) |
Issued | 25 years, 1 month ago (Aug. 1, 2000) |
Published | 25 years, 1 month ago (Aug. 1, 2000) |
Published Print | 25 years, 1 month ago (Aug. 1, 2000) |
@article{Zhang_2000, title={Oxidative Stress and Genetics in the Pathogenesis of Parkinson’s Disease}, volume={7}, ISSN={0969-9961}, url={http://dx.doi.org/10.1006/nbdi.2000.0319}, DOI={10.1006/nbdi.2000.0319}, number={4}, journal={Neurobiology of Disease}, publisher={Elsevier BV}, author={Zhang, Yi and Dawson, Valina L. and Dawson, Ted M.}, year={2000}, month=aug, pages={240–250} }